Skip to main content
. 2023 Mar 2;31(1):13–27. doi: 10.12793/tcp.2023.31.e1

Table 8. Changes in hematological parameters between groups.

Laboratory investigations Treatment Placebo
Baseline Day 90 Baseline Day 90
Total leukocyte count 8,145.16 ± 2,212.67 7,603.23 ± 1,762.48 8,493.10 ± 2,289.09 9,041.38 ± 3,392.69
Neutrophil % 58.87 ± 5.89 64.45 ± 8.19 59.31 ± 8.69 64.79 ± 8.91
Lymphocyte % 34.10 ± 5.56 29.32 ± 7.85 32.45 ± 7.42 28.79 ± 7.94
Monocyte % 3.42 ± 1.20 3.39 ± 1.58 3.83 ± 1.47 3.31 ± 1.61
Eosinophil % 3.61 ± 1.23 4.06 ± 1.26 4.41 ± 1.88 4.10 ± 1.57
Total RBC 4.63 ± 0.62 4.57 ± 0.48 4.90 ± 0.54 4.64 ± 0.56
Hemoglobin 12.90 ± 2.00 12.96 ± 1.77 13.78 ± 1.74 13.68 ± 1.56
Platelet count 228,451.61 ± 60,378.16 264,225.81 ± 85,040.27 208,379.31 ± 70,893.99 245,206.90 ± 69,788.14

Data analyzed by Student’s t-test. Not significant at p < 0.05.